BE823104A - Nouvelles acetamidocephalosporines substituees - Google Patents

Nouvelles acetamidocephalosporines substituees

Info

Publication number
BE823104A
BE823104A BE151288A BE151288A BE823104A BE 823104 A BE823104 A BE 823104A BE 151288 A BE151288 A BE 151288A BE 151288 A BE151288 A BE 151288A BE 823104 A BE823104 A BE 823104A
Authority
BE
Belgium
Prior art keywords
acetamidocephalosporins
substitutes
new
new acetamidocephalosporins
acetamidocephalosporins substitutes
Prior art date
Application number
BE151288A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE823104A publication Critical patent/BE823104A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
BE151288A 1973-12-26 1974-12-09 Nouvelles acetamidocephalosporines substituees BE823104A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/428,536 US3957770A (en) 1973-12-26 1973-12-26 Substituted acetamidocephalosporins

Publications (1)

Publication Number Publication Date
BE823104A true BE823104A (fr) 1975-06-09

Family

ID=23699300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE151288A BE823104A (fr) 1973-12-26 1974-12-09 Nouvelles acetamidocephalosporines substituees

Country Status (13)

Country Link
US (1) US3957770A (fr)
JP (1) JPS50105690A (fr)
BE (1) BE823104A (fr)
CA (1) CA1041086A (fr)
CH (1) CH612437A5 (fr)
DE (1) DE2460658A1 (fr)
ES (1) ES433300A1 (fr)
FR (1) FR2255911B1 (fr)
GB (1) GB1449398A (fr)
IE (1) IE40455B1 (fr)
LU (1) LU71488A1 (fr)
NL (1) NL7416856A (fr)
ZA (1) ZA747405B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020057A (en) * 1975-06-18 1977-04-26 Smithkline Corporation 7β-Acyloxy cephalosporins
JPS5814440B2 (ja) * 1976-01-29 1983-03-18 旭化成株式会社 セファロスポリン類

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828037A (en) * 1972-07-20 1974-08-06 Smithkline Corp Trifluoromethylmercaptoacetamidocephalosporins

Also Published As

Publication number Publication date
IE40455B1 (en) 1979-06-06
FR2255911A1 (fr) 1975-07-25
LU71488A1 (fr) 1975-06-17
IE40455L (en) 1975-06-26
ES433300A1 (es) 1977-03-01
AU7586974A (en) 1976-06-03
NL7416856A (nl) 1975-06-30
CA1041086A (fr) 1978-10-24
FR2255911B1 (fr) 1978-07-28
DE2460658A1 (de) 1975-07-10
JPS50105690A (fr) 1975-08-20
CH612437A5 (fr) 1979-07-31
GB1449398A (en) 1976-09-15
US3957770A (en) 1976-05-18
ZA747405B (en) 1975-12-31

Similar Documents

Publication Publication Date Title
BE810921A (fr) Nouvelles dihydropyridines
AT338352B (de) Ohrstuck
BE823103A (fr) Nouvelles aryl-dihydro-pyridazinones substituees
AT359180B (de) Osteotom
DK140348C (da) Forskalling
BE813158A (fr) Nouvelles benzoquinolizines
FI54454C (fi) Vridbar saekerhetskapsyl
BE814229A (fr) Nouvelles azolylamidines
AT329420B (de) Monoschi
BE810147A (fr) Thiourees n
FI55805C (fi) Bindningsmaskin
SE397282B (sv) Vetskekyld kokill
BE819773A (fr) Nouvelles benzylpyrimidines
BE814114A (fr) Alpha-alkylbenzyl-lactamimides substitues
FR2295005A1 (fr) Nouvelles substances odoriferantes
AT342382B (de) Flussmittel
BE817294A (fr) Nouvelles sulfonyloxyphenylurees
BE813677A (fr) Nouvelles triazolo-1
AT354042B (de) Raffstore
BE824924A (fr) Nouvelles tetrahydroisoquinoleines substituees
BE818131A (fr) Nouvelles benzylpyrimidines
BE813947A (fr) Nouvelles dichlorothiazolylurees
BE810364A (fr) Nouvelles benzoylphenylguanidines
BE817364A (fr) (5-phenylsulfinyl-2-benzimidazolyl)-carbamates
BE823104A (fr) Nouvelles acetamidocephalosporines substituees

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITHKLINE CORP.

Effective date: 19861231